AUPH
AUPH clinical trials: Aurinia Pharmaceuticals Inc.
Every trial on ClinicalTrials.gov where Aurinia Pharmaceuticals Inc. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 20
- Trials linked
- 19
- As lead sponsor
- 1
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
AUPH on the catalyst calendar · AUPH registry changes
- Primary completion Mar 2, 2029Sponsor estimatePhase 4NCT07611214PRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus NephritisAurinia Pharmaceuticals Inc. · Lupus NephritisRecruitingAUPHLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 2, 2029Sponsor estimatePhase 1/Phase 2NCT07596901Study of Aritinercept in Patients With Generalized Myasthenia GravisAurinia Pharmaceuticals Inc. · Myasthenia Gravis, GeneralizedRecruitingAUPHLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 4, 2025ActualPhase 3NCT05962788Long-Term Voclosporin Treatment in Adolescent and Pediatric Subjects With Lupus NephritisAurinia Pharmaceuticals Inc. · Adolescent Lupus NephritisTerminatedAUPHLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 3, 2025ActualPhase 3NCT05288855Voclosporin in Adolescent and Pediatric Subjects With Lupus NephritisAurinia Pharmaceuticals Inc. · Adolescent Lupus NephritisTerminatedAUPHLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 31, 2025ActualNo phase registeredNCT05337124A Prospective Observational Registry of Patients Treated With LUPKYNIS® (Voclosporin) in the USAurinia Pharmaceuticals Inc. · Lupus NephritisCompletedAUPHLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 24, 2019ActualPhase 3NCT03021499Aurinia Renal Response in Active Lupus With VoclosporinAurinia Pharmaceuticals Inc. · Lupus NephritisCompletedAUPHLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Oct 2005ActualPhase 3NCT00244842Randomized Placebo-controlled Study of ISA247 in Plaque PsoriasisAurinia Pharmaceuticals Inc. · PsoriasisCompletedAUPHLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Oct 7, 2021ActualPhase 3NCT03597464Aurinia Renal Assessments 2: Aurinia Renal Response in Lupus With VoclosporinAurinia Pharmaceuticals Inc. · Lupus NephritisCompletedAUPHLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 5, 2022ActualPhase 1NCT05306379Drug-Drug Interaction Study to Investigate Effects of Voclosporin on Pharmacokinetics of SimvastatinAurinia Pharmaceuticals Inc. · Drug-drug InteractionCompletedAUPHLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 17, 2020ActualPhase 2/Phase 3NCT04147650Dose Ranging Study to Assess the Efficacy and Safety of Voclosporin Ophthalmic Solution in Subjects With Dry Eye SyndromeAurinia Pharmaceuticals Inc. · Dry Eye SyndromeCompletedAUPHLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 19, 2020ActualPhase 2NCT03598036Dose-Exploration Evaluating the Efficacy and Safety of Voclosporin in Subjects With Focal Segmental GlomerulosclerosisAurinia Pharmaceuticals Inc. · Focal Segmental GlomerulosclerosisTerminatedAUPHLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Nov 9, 2018ActualPhase 2NCT03597139Ocular Tolerability of Voclosporin Ophthalmic Solution Versus Restasis® in Subjects With Dry Eye DiseaseAurinia Pharmaceuticals Inc. · Dry EyeCompletedAUPHLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 2016ActualPhase 2NCT02141672AURA-LV: Aurinia Urinary Protein Reduction Active - Lupus With Voclosporin (AURA-LV)Aurinia Pharmaceuticals Inc. · Lupus NephritisCompletedAUPHLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 2016ActualPhase 2NCT02949973Aurinia Early Urinary Protein Reduction Predicts ResponseAurinia Pharmaceuticals Inc. · Lupus NephritisCompletedAUPHLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 2016ActualPhase 1NCT02949999Voclosporin in Healthy Japanese VolunteersAurinia Pharmaceuticals Inc. · VolunteersCompletedAUPHLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 2015Sponsor estimatePhase 3NCT01586845Safety and Efficacy Study of Voclosporin and Tacrolimus in TransplantationAurinia Pharmaceuticals Inc. · Renal TransplantationWithdrawnAUPHLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 2009ActualPhase 2NCT00270634Study of ISA247 (Voclosporin) in De Novo Renal TransplantationAurinia Pharmaceuticals Inc. · Kidney DiseasesCompletedAUPHLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 2008ActualPhase 3NCT00408187Randomized, Placebo and Ciclosporin Controlled Study of ISA247 in Plaque Psoriasis PatientsAurinia Pharmaceuticals Inc. · PsoriasisCompletedAUPHLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 2006ActualPhase 3NCT00258713A 36-Week Extension to Protocol ISA04-03Aurinia Pharmaceuticals Inc. · PsoriasisCompletedAUPHLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 25, 2022ActualPhase 2NCT04701528Anti-Viral Effects of Voclosporin in COVID-19 Positive Kidney Transplant RecipientsLeiden University Medical Center · Covid19CompletedAUPHCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 20 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner